News & Events category:
NIHR Manchester Clinical Research Facility

Cellular (T-cell) immunity against SARS-CoV-2 is likely to be present within most adults for at least six months after infection, according to research carried out at MFT.

More than 600 school children and teachers in Greater Manchester have taken part in a new voluntary coronavirus study, which is assessing the prevalence of COVID-19 in school pupils and teachers.

Our first patient has taken part in a new clinical trial investigating potential treatments for COVID-19, as part of a nationwide research effort to meet the challenge of coronavirus.

Our first patient has participated in the RUXCOVID research trial, which is testing whether the drug ruxolitinib could be a potential treatment for COVID-19 (coronavirus).

Staff at MFT, already caring for patients on the frontline, are now helping fight the battle against COVID-19 by taking part in research

MFT has recruited more than 400 patients to research trials in an attempt to better understand and treat COVID-19.

In an unprecedented move, scientists and clinicians across Greater Manchester have formed a Rapid Response Research Group to find ways to beat COVID-19 and save lives.